Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent, Cem Akin, Karin Hartmann, et al.
Cancer Research (2017) Vol. 77, Iss. 6, pp. 1261-1270
Open Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

The pathophysiology of anaphylaxis
Laurent L. Reber, Joseph D. Hernandez, Stephen J. Galli
Journal of Allergy and Clinical Immunology (2017) Vol. 140, Iss. 2, pp. 335-348
Open Access | Times Cited: 416
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
HemaSphere (2021) Vol. 5, Iss. 11, pp. e646-e646
Open Access | Times Cited: 204
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Joakim S. Dahlin, Marcus Maurer, Dean D. Metcalfe, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 83-99
Open Access | Times Cited: 111
Anaphylaxis: A 2023 practice parameter update
David B.K. Golden, Julie Wang, Susan Waserman, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 2, pp. 124-176
Open Access | Times Cited: 87
Urticaria and Angioedema: an Update on Classification and Pathogenesis
Susanne Radonjic‐Hoesli, Kathrin Scherer, Sara Micaletto, et al.
Clinical Reviews in Allergy & Immunology (2017) Vol. 54, Iss. 1, pp. 88-101
Open Access | Times Cited: 138
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Blood (2020) Vol. 137, Iss. 2, pp. 238-247
Open Access | Times Cited: 135
Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond
Emery H. Bresnick, Kyle J. Hewitt, Charu Mehta, et al.
Development (2018) Vol. 145, Iss. 1
Open Access | Times Cited: 123
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Peter Valent, Attilio Orazi, Michael R. Savona, et al.
Haematologica (2019) Vol. 104, Iss. 10, pp. 1935-1949
Open Access | Times Cited: 118
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis
Andreas Reiter, Tracy I. George, Jason Gotlib
Blood (2020) Vol. 135, Iss. 16, pp. 1365-1376
Open Access | Times Cited: 112
Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer
Maria Rosaria Galdiero, Gilda Varricchi, Mansour Seaf, et al.
Frontiers in Medicine (2017) Vol. 4
Open Access | Times Cited: 105
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
Peter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1999-2012.e6
Open Access | Times Cited: 47
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy
Peter Valent, Cem Akin, Wolfgang R. Sperr, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 361-386
Open Access | Times Cited: 40
Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Archives of Allergy and Immunology (2022) Vol. 183, Iss. 7, pp. 693-705
Open Access | Times Cited: 39
Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study
M. Jørgensen, Andreas Kiesbye Øvlisen, Jonas Jensen, et al.
European Journal of Epidemiology (2025)
Open Access | Times Cited: 1
The transcriptional program, functional heterogeneity, and clinical targeting of mast cells
Gökhan Cildir, Harshita Pant, Angel F. López, et al.
The Journal of Experimental Medicine (2017) Vol. 214, Iss. 9, pp. 2491-2506
Open Access | Times Cited: 86
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Jakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová, et al.
Allergy (2020) Vol. 75, Iss. 8, pp. 1927-1938
Open Access | Times Cited: 60
Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS
Richard Lemal, Guillemette Fouquet, Louis Terriou, et al.
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 7, Iss. 7, pp. 2387-2395.e3
Open Access | Times Cited: 58
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I. Muñoz‐González, Iván Álvarez‐Twöse, María Jara‐Acevedo, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 3, pp. e194-e204
Closed Access | Times Cited: 51
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
Gregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1953-1963
Open Access | Times Cited: 37
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
Roberta Parente, Valentina Giudice, Chiara Cardamone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7071-7071
Open Access | Times Cited: 17
Cutaneous Mastocytosis in Adults and Children
Almudena Matito, José Manuel Azaña Defez, Antonio Torrelo, et al.
Immunology and Allergy Clinics of North America (2018) Vol. 38, Iss. 3, pp. 351-363
Closed Access | Times Cited: 55
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives
Peter Valent, J. N. G. Oude Elberink, Aleksandra Górska, et al.
The Journal of Allergy and Clinical Immunology In Practice (2018) Vol. 7, Iss. 1, pp. 81-87
Open Access | Times Cited: 52
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C. Kluin‐Nelemans, Andreas Reiter, Anja Illerhaus, et al.
Leukemia (2019) Vol. 34, Iss. 4, pp. 1090-1101
Open Access | Times Cited: 49
Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial
Björn van Anrooij, Joanne N.G. Oude Elberink, Lambert F. R. Span, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 142, Iss. 3, pp. 1006-1008.e7
Open Access | Times Cited: 48
Mast Cells in Liver Fibrogenesis
Ralf Weiskirchen, Steffen K. Meurer, Christian Liedtke, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1429-1429
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top